Lung cancer is treated with many conventional therapies, such as surgery, radiation, and
chemotherapy. However, these therapies have multiple undesirable side effects. To bypass …

Simple Summary Secondary amplifications/copy number changes of the gene MET (MET
protocol oncogene) play a significant role in the development of resistance to targeted drugs …

Simple Summary Non-small cell lung cancer (NSCLC) patients acquire resistance to
tyrosine kinase inhibitors (TKIs) via EGFR mutations or overexpression of vascular …

Although epidermal growth factor receptor (EGFR) inhibitors have been used to treat non-
small cell lung cancer (NSCLC) for decades with great success in patients with EGFR …

Mitochondrial transcription factor A (TFAM) is essential for the replication, transcription and
maintenance of mitochondrial DNA (mtDNA). The role of TFAM in non-small cell lung cancer …

Recently, technological advances in the detection and biological characterization of
circulating tumor DNA (ctDNA) have enabled the implementation of liquid biopsy testing into …

Cancer has been in existence longer than human beings, and man has been facing the
illness ever since he made his appearance on Earth. Amazingly, the first human cancer …

Lung cancer being the most prevalent malignancy in men and the 3 rd most frequent in
women is still associated with dismal prognosis due to advanced disease at the time of …

A large variety of processes and tools has been investigated to acquire better knowledge on
the natural evolution of healthy or pathological tissues in 3D scaffolds to discover new …

Lung cancer is one of the most common malignant tumors. A growing body of evidence has
demonstrated that circulating microRNAs (miRNAs) have great potential for the diagnosis …